Number of Prostate Cancer Cases Set to Increase to 2.9 Million in 2040
By Elana Gotkine HealthDay Reporter
FRIDAY, April 5, 2024 -- The number of new prostate cancer cases is set to increase to 2.9 million in 2040, according to a study published online April 4 in The Lancet.
Nicholas D. James, M.B.B.S., Ph.D., from the Institute of Cancer Research in London, and colleagues reported projections of prostate cancer cases in 2040 based on data for demographic changes worldwide and increasing life expectancy.
The authors note that the number of new cases of prostate cancer is projected to increase from 1.4 million in 2020 to 2.9 million in 2040. Large increases in disease are expected due to changing age structure and improving life expectancy. Lifestyle changes and public health interventions cannot prevent the projected rise in prostate cancer cases. Late diagnosis of prostate cancer is widespread, especially in low- and middle-income countries (LMIC), where it is the norm. Systems for earlier diagnosis are urgently needed to mitigate the harm caused by rising case numbers, especially in LMICs. To improve early diagnosis, trials of screening are urgently needed, the authors state. The increase in prostate cancer is likely to be reflected in increases in other conditions, and consequently, early diagnosis programs should focus on men's health more broadly. A key research priority is better understanding of ethnic differences in disease prevalence, because rates of prostate cancer are twice as high in men of African heritage. The authors conclude that treatment of advanced prostate cancer remains problematic, and affordable therapies are unevenly distributed.
"In view of the large projected rise in cases, long-term changes need to be rolled out from now if large increases in prostate cancer deaths are to be prevented," the authors write.
Several authors disclosed ties to the pharmaceutical, biotechnology, and diagnostics industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.